CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients

European Journal of Cancer

Volumn 51, Issue 17, 2015, Pages 2624-2633

  Sand, L G L ^a   Scotlandi, K ^b   Berghuis, D ^a   Snaar Jagalska, B E ^c   Picci, P ^b   Schmidt, T ^d   Szuhai, K ^a   Hogendoorn, P C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratorio di Ricerca Oncologica   (Italy)

^c LEIDEN UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Biomarker; Molecular targeted therapy; Splice variant; Tumour microenvironment

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL14 CHEMOKINE; RNA; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR; CXCL12 PROTEIN, HUMAN; CXCL14 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; ISOPROTEIN; STROMAL CELL DERIVED FACTOR 1;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; EWING SARCOMA; EWING SARCOMA CELL LINE; FEMALE; HUMAN; HUMAN CELL; MALE; METASTASIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; SCHOOL CHILD; YOUNG ADULT; BONE TUMOR; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADOLESCENT; ADULT; BONE NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL12; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTEIN ISOFORMS; RECEPTORS, CXCR; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; SARCOMA, EWING; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84969802556     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.08.020     Document Type: Article

References (38)

1. E. De Alava, S.L. Lessnick, and P.H. Sorensen Ewing sarcoma C.D.M. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens, WHO classification of tumors of soft tissue and bone 4th ed. 2013 IARC Lyon 306 309
2. L.G.L. Sand, K. Szuhai, and P.C.W. Hogendoorn Sequencing overview of Ewing sarcoma: a journey across genomic, epigenomic and transcriptomic landscapes Int J Mol Sci 16 2015 16176 16215
3. G. Pierron, F. Tirode, C. Lucchesi, S. Reynaud, S. Ballet, S. Cohen-Gogo, and et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion Nat Genet 44 2012 461 466
4. K. Szuhai, M. IJszenga, D. de Jong, A. Karseladze, H.J. Tanke, and P.C.W. Hogendoorn The NFATC2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology Clin Cancer Res 15 2009 2259 2268
5. C. Graham, S. Chilton-MacNeill, M. Zielenska, and G.R. Somers The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas Hum Pathol 43 2012 180 189
6. N.J. Balamuth, and R.B. Womer Ewing's sarcoma Lancet Oncol 11 2010 184 192
7. M.-C. Le Deley, O. Delattre, K.-L. Schaefer, S.A. Burchill, G. Koehler, P.C.W. Hogendoorn, and et al. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-EWING 99 trial J Clin Oncol 28 2010 1982 1988
8. G. Bacci, S. Ferrari, A. Longhi, D. Donati, M. De Paolis, C. Forni, and et al. Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997 Ann Oncol 14 2003 1654 1659
9. R. Ladenstein, U. Pötschger, M.C. Le Deley, J. Whelan, M. Paulussen, O. Oberlin, and et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial J Clin Oncol 28 2010 3284 3291
10. A. van Maldegem, P. Hogendoorn, and A. Hassan The clinical use of biomarkers as prognostic factors in Ewing sarcoma Clin Sarcoma Res 2 2012 7
11. J. Ewing Diffuse endothelioma of bone Proc N Y Pathol Soc 21 1921 8
12. S.G. DuBois, N. Marina, and J. Glade-Bender Angiogenesis and vascular targeting in Ewing sarcoma Cancer 116 2010 749 757
13. E. Pardali, D.W.J. van der Schaft, E. Wiercinska, A. Gorter, P.C.W. Hogendoorn, A.W. Griffioen, and et al. Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma Oncogene 30 2011 334 345
14. C. Bühnemann, S. Li, H. Yu, H. Branford White, K.L. Schäfer, A. Llombart-Bosch, and et al. Quantification of the heterogeneity of prognostic cellular biomarkers in Ewing sarcoma using automated image and random survival forest analysis PLoS One 9 2014 e107105
15. D. Berghuis, M.W. Schilham, S.J. Santos, S. Savola, H. Knowles, U. Dirksen, and et al. The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease Clin Sarcoma Res 2 2012 24
16. I.M. Bennani-Baiti, A. Cooper, E.R. Lawlor, M. Kauer, J. Ban, D.N.T. Aryee, and et al. Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma Clin Cancer Res 16 2010 3769 3778
17. B.E. Lippitz Cytokine patterns in patients with cancer: a systematic review Lancet Oncol 14 2013 e218 e228
18. K. Tanegashima, K. Suzuki, Y. Nakayama, K. Tsuji, A. Shigenaga, A. Otaka, and et al. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis FEBS Lett 587 2013 1731 1735
19. U.M. Domanska, R.C. Kruizinga, W.B. Nagengast, H. Timmer-Bosscha, G. Huls, E.G.E. de Vries, and et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide Eur J Cancer 49 2013 219 230
20. S.K. Gupta, and K. Pillarisetti Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant J Immunol 163 1999 2368 2372
21. P. Tamamis, and C.A. Floudas Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4 J Chem Inf Model 54 2014 1174 1188
22. F.J. van Kuppeveld, J.T. van der Logt, A.F. Angulo, M.J. van Zoest, W.G. Quint, H.G. Niesters, and et al. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification Appl Environ Microbiol 58 1992 2606 2615
23. A. Mortazavi, B.A. Williams, K. McCue, L. Schaeffer, and B. Wold Mapping and quantifying mammalian transcriptomes by RNA-seq Nat Methods 5 2008 621 628
24. D.O. Bates, P.J. Catalano, K.E. Symonds, A.H.R. Varey, P. Ramani, P.J. O'Dwyer, and et al. Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab Clin Cancer Res 18 2012 6384 6391
25. P.C.W. Hogendoorn, N. Athanasou, S. Bielack, E. De Alava, A.P.D. Tos, S. Ferrari, and et al. Bone sarcomas: EMSO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 21 2010 v204 v213
26. F.M. Décaillot, M.A. Kazmi, Y. Lin, S. Ray-Saha, T.P. Sakmar, and P. Sachdev CXCR7/CXCR4 heterodimer constitutively recruits β-arrestin to enhance cell migration J Biol Chem 286 2011 32188 32197
27. M.A. Krook, L.A. Nicholls, C.A. Scannell, R. Chugh, D.G. Thomas, and E.R. Lawlor Stress-induced CXCR4 promotes migration and invasion of Ewing sarcoma Mol Cancer Res 12 2014 953 964
28. L. Ding, and S.J. Morrison Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches Nature 495 2013 231 235
29. R.D. Berahovich, B.A. Zabel, S. Lewén, M.J. Walters, K. Ebsworth, Y. Wang, and et al. Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels Immunology 141 2014 111 122
30. L.B. Rivera, D. Meyronet, V. Hervieu, M.J. Frederick, E. Bergsland, and G. Bergers Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy Cell Rep 11 2015 577 591
31. L. Sánchez-Martín, P. Sánchez-Mateos, and C. Cabañas CXCR7 impact on CXCL12 biology and disease Trends Mol Med 19 2013 12 22
32. F. Hoffmann, W. Müller, D. Schütz, M.E. Penfold, Y.H. Wong, S. Schulz, and et al. Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues J Biol Chem 287 2012 28362 28377
33. C. Steidl, T. Lee, S.P. Shah, P. Farinha, G. Han, T. Nayar, and et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma N Engl J Med 362 2010 875 885
34. E.P. Buddingh, M.L. Kuijjer, R.A.J. Duim, H. Bürger, K. Agelopoulos, O. Myklebost, and et al. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents Clin Cancer Res 17 2011 2110 2119
35. R. Hamdan, Z. Zhou, and E.S. Kleinerman Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors Mol Cancer Therapeut 2013
36. F. Daubeuf, M. Hachet-Haas, P. Gizzi, V. Gasparik, D. Bonnet, V. Utard, and et al. An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice J Biol Chem 288 2013 11865 11876
37. K. Tanegashima, K. Tsuji, K. Suzuki, A. Shigenaga, A. Otaka, and T. Hara Dimeric peptides of the c-terminal region of CXCL14 function as CXCL12 inhibitors FEBS Lett 587 2013 3770 3775
38. W. van der Ent, A.G. Jochemsen, A.F.A.S. Teunisse, S.F.G. Krens, K. Szuhai, H.P. Spaink, and et al. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53 J Pathol 233 2014 415 424